Prescription weight-management medications may be used (in combination with a reduced-calorie diet and increased physical activity) for people with one of the following conditions: A body mass index (BMI) of 30 or higher A BMI of 27 or higher with a weight-related condition, such as high blood pressure or type 2 diabetes GLP-1s and weight-management medications may also be prescribed for reasons outside of this list
Tirzepatides dual GLP-1 and GIP receptor activity translates into enhanced metabolic and weight-loss benefits compared to GLP-1 monotherapy. While semaglutide remains a trusted choice for both diabetes and obesity, these findings suggest tirzepatide may offer an extra edge
FOR SAXENDA SOURCE: DailyMed
Furthermore, GIPR antagonists increase metabolism in obese mice, and when combined with GLP1RAs, both GIPR agonists and antagonists have beneficial therapeutic effects
If you have questions about GLP-1 medications, changes in your metabolism, or how to manage your energy levels while on these treatments, dont hesitate to reach out